Baker Avenue Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Buy
+3,092
New +$206K ﹤0.01% 777
2023
Q4
Sell
-61
Closed -$5.69K 672
2023
Q3
$5.69K Buy
61
+6
+11% +$676 ﹤0.01% 905
2023
Q2
$7.07K Sell
55
-39
-41% -$4.72K ﹤0.01% 797
2023
Q1
$10.9K Buy
94
+29
+45% +$3.25K ﹤0.01% 750
2022
Q4
$7.36K Buy
+65
New +$7.14K ﹤0.01% 752

Other funds holding DXCM

Baker Avenue Asset Management's DXCM Position: Q2 2026 in Review

Baker Avenue Asset Management opened a new position in DexCom (DXCM) in Q2 2026: 3,092 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Baker Avenue Asset Management previously reported a position in DXCM as recently as Q3 2023.

Baker Avenue Asset Management first reported a position in DXCM in Q4 2022 and has held it in 5 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Baker Avenue Asset Management held 3,092 shares of DexCom worth $208K as of Q2 2026.
  • DexCom was a new Baker Avenue Asset Management position in Q2 2026.
  • DexCom made up ﹤0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #777 holding.
  • Baker Avenue Asset Management first reported a position in DexCom in Q4 2022 and has held it in 5 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.